Thrombin activatable fibrinolysis inhibitor in Behçet's disease-Reference-Cited by-同舟云学术

Thrombin activatable fibrinolysis inhibitor in Behçet's disease

Published:2005-01 Issue:4 Volume:115 Page:287-292
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Donmez Ayhan,Aksu Kenan,Celik Handan Ak,Keser Gokhan,Cagirgan Seckin,Omay Serdar Bedii,Inal Vedat,Aydin Hikmet Hakan,Tombuloglu Murat,Doganavsargil Eker

Publisher

Elsevier BV

Subject

Hematology

Reference33 articles.

1. Über rezidiverende aphthöse durch ein virus verursachte Geschwüre am Mund, am Auge, und an den Genitalien;Behçet;Dermatol. Wochenschr.,1937

2. Vascular involvement in Behçet's disease;Koc;J. Rheumatol.,1992

3. Thrombosis in Behçet's disease: a retrospective survey from a single UK centre;Ames;Rheumatology,2001

4. Behçet's syndrome;Yazici,1998

5. Impaired haemostatic kinetics and endothelial function in Behçet's disease;Haznedaroglu;J. Intern. Med.,1996

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum thrombin‐activatable fibrinolysis inhibitor levels and its relation with pathogenesis and bleeding and prognosis in patients with Crimean Congo hemorrhagic fever;Journal of Medical Virology;2022-10-08

2. Increased ischemic stroke risk in patients with Behçet’s disease: A nationwide population-based cohort study;PLOS ONE;2019-06-25

3. Plasma Thrombin-activatable Fibrinolysis Inhibitor Levels Correlate with the Disease Activity of Ulcerative Colitis;Internal Medicine;2016

4. Thrombosis in vasculitic disorders−clinical manifestations, pathogenesis and management;Thrombosis Research;2015-09

5. Thrombosis in Systemic Lupus Erythematosus: Role of Impaired Fibrinolysis;Seminars in Thrombosis and Hemostasis;2013-03-16